AKT1 and acute lymphoblastic leukemia: We analyzed by MTS assay the IC50 values of 5 different inhibitors, some of which targeted both mTOR complexes, and 5 drugs with direct inhibition of PI3K/Akt pathway in ALL-SIL, PEER and BE-13 cell lines.